Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort

BACKGROUND: The nature of the COVID-19 pandemic led to concerns among patients and physicians about the potential impact of immunosuppressive treatments for chronic diseases such as psoriasis on the risk of severe COVID-19. OBJECTIVES: To describe treatment modifications and determine the incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Arlegui, H., Mahé, E., Richard, M.-A., De Rycke, Y., Viguier, M., Beylot-Barry, M., Dupuy, A., Beneton, N., Joly, P., Jullien, D., Bachelez, H., Sbidian, É., Chosidow, O., Paul, C., Tubach, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928748/
https://www.ncbi.nlm.nih.gov/pubmed/36914553
http://dx.doi.org/10.1016/j.annder.2023.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928748/
https://www.ncbi.nlm.nih.gov/pubmed/36914553
http://dx.doi.org/10.1016/j.annder.2023.01.005

Ejemplares similares